The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 2-12C ALL: Clinical (3)

Sat. Oct 12, 2019 2:50 PM - 3:50 PM No.12 (Tokyo International Forum, 5F G510)

Chair: Motohiro Kato (National Center for Child Health and Development)

[OS2-12C-4] Immunomonitoring for TKI-resistant Ph+ALL patients who respond to blinatumomab therapy

Junichiro Yuda1,2,3, Nobuhiko Yamauchi1, Kenichi Miyamoto1, Yusuke Kamihara1, Yumi Osada1,2, Hiroyoshi Nishikawa2, Yosuke Minami1 (1.National Cancer Center Hospital East, Department of Hematology, 2.Division of Cancer Immunology, National Cancer Center, 3.National Cancer Center Hospital East, Department Experimental Therapeutics)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password